The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathogenic germline variant prevalence and genetic testing outcomes in patients with urothelial carcinoma.
 
Eugene Oh
No Relationships to Disclose
 
Piroz Bahar
No Relationships to Disclose
 
Ye Chua
No Relationships to Disclose
 
Marie-Louise Accardo
No Relationships to Disclose
 
Xiaochen Li
No Relationships to Disclose
 
Erika Koeppe
No Relationships to Disclose
 
Phillip Palmbos
Research Funding - Immunomedics; Roche
 
Irene Tsung
No Relationships to Disclose
 
Zachery Reichert
Consulting or Advisory Role - AstraZeneca; Janssen Oncology
Research Funding - AstraZeneca (Inst)
Expert Testimony - Huff Bowell Bailey
 
Ulka Vaishampayan
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Exelixis; Gilead Sciences; Janssen Oncology; Merck Serono; Mural; Pfizer; Pfizer/Astellas; Sumitomo Pharma Oncology
Research Funding - Bristol-Myers Squibb; Merck KGaA
 
Tobias Else
Consulting or Advisory Role - HRA Pharma; Lantheus Medical Imaging; Merck
Research Funding - Corcept Therapeutics
 
Charles Nguyen
No Relationships to Disclose